GSK plc (GSK) Stock Overview
Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.
GSK plc (GSK)
Key Financials
Key Financials
Market Cap
103.7B
P/E Ratio
13.36
EPS (TTM)
$3.82
ROE
0.28%
GSK Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of GSK plc (GSK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.36, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $57.73.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.36 and a market capitalization of 103.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.